Lipid-lowering effect of tenofovir in HIV-infected patients

被引：27
|
作者：
Fabbiani, Massimiliano [1 ]
Bracciale, Laura [1 ]
Doino, Maria [1 ]
Sidella, Letizia [1 ]
Farina, Salvatore [1 ]
Di Cristo, Valentina [1 ]
Cauda, Roberto [1 ]
De Luca, Andrea [1 ,2 ]
Di Giambenedetto, Simona [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, I-00168 Rome, Italy
[2] Siena Univ Hosp, Infect Dis Unit 2, Siena, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 03期
关键词：
cholesterol; simplification; antiretroviral therapy; cardiovascular risk;
D O I：
10.1093/jac/dkq464
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [1] Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients
    Gagliardini, Roberta
    Fabbiani, Massimiliano
    Colafigli, Manuela
    D'Avino, Alessandro
    Mondi, Annalisa
    Borghetti, Alberto
    Lamonica, Silvia
    Cauda, Roberto
    De Luca, Andrea
    Di Giambenedetto, Simona
    JOURNAL OF CHEMOTHERAPY, 2017, 29 (05) : 299 - 307
  • [2] Lipid-Lowering Effect and Efficacy After Switching to Etravirine in HIV-Infected Patients With Intolerance to Suppressive HAART
    Casado, Jose L.
    de los Santos, Ignacio
    del Palacio, Maria
    Garcia-Fraile, Lucio
    Perez-Elias, Maria J.
    Sanz, Jesus
    Moreno, Santiago
    HIV CLINICAL TRIALS, 2013, 14 (01): : 1 - 9
  • [3] Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins
    Negredo, Eugenia
    Molto, Jose
    Puig, Jordi
    Cinquegrana, Denise
    Bonjoch, Anna
    Perez-Alvarez, Nuria
    Lopez-Blazquez, Raquel
    Blanco, Asuncion
    Clotet, Bonaventura
    Rey-Joly, Celestino
    AIDS, 2006, 20 (17) : 2159 - 2164
  • [4] The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients
    Bain, A. M.
    Payne, K. D.
    Rahman, A. P.
    Bedimo, R.
    Maclayton, D. O.
    Rodriguez-Barradas, M.
    Busti, A. J.
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2008, 4 (02) : 147 - 151
  • [5] Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders
    Bednasz, Cindy
    Luque, Amneris E.
    Zingman, Barry S.
    Fischl, Margaret A.
    Gripshover, Barbara M.
    Venuto, Charles S.
    Gu, Jie
    Feng, Zekun
    DiFrancesco, Robin
    Morse, Gene D.
    Ma, Qing
    CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (03) : 280 - 287
  • [6] Effectiveness of lipid-lowering therapy in HIV patients
    Martinez, Esteban
    Leyes, Pere
    Ros, Emilio
    CURRENT OPINION IN HIV AND AIDS, 2008, 3 (03) : 240 - 246
  • [7] Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy
    Fredriksen, J
    Ueland, T
    Dyroy, E
    Halvorsen, B
    Melby, K
    Melbye, L
    Skalhegg, BS
    Bohov, P
    Skorve, J
    Berge, RK
    Aukrust, P
    Froland, SS
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (10) : 709 - 715
  • [8] Lipid-lowering agents for dyslipidemia in patients who were infected with HIV in Taoyuan, Taiwan
    Cheng, Shu-Hsing
    Cheng, Chien-Yu
    Sun, Na-Lee
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 46 - 47
  • [9] The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients
    Kiser, J. J.
    Carten, M. L.
    Aquilante, C. L.
    Anderson, P. L.
    Wolfe, P.
    King, T. M.
    Delahunty, T.
    Bushman, L. R.
    Fletcher, C. V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 265 - 272
  • [10] Effect of Darunavir on Lipid Profile in HIV-Infected Patients
    Overton, Edgar Turner
    Arathoon, Eduardo
    Baraldi, Ezio
    Tomaka, Frank
    HIV CLINICAL TRIALS, 2012, 13 (05): : 256 - 270
12345